Astigmatism Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Patient based Forecast by DelveInsight | Novartis AG, SeaVision USA, Johnson & Johnson, Bausch & Lomb Incorp

August 23 23:15 2023
Astigmatism Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Patient based Forecast by DelveInsight | Novartis AG, SeaVision USA, Johnson & Johnson, Bausch & Lomb Incorp
Astigmatism Market

(New York, USA) DelveInsight’s “Astigmatism Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Astigmatism, historical and forecasted epidemiology as well as the Astigmatism market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.

The Astigmatism market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted Astigmatism market size from 2019 to 2032, segmented by seven major markets. The Report also covers current Astigmatism treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best opportunities and assesses the underlying potential of the Astigmatism market.


Request for a Free Sample Report @ Astigmatism Market Forecast


Some facts of the Astigmatism Market Report are:

  • According to DelveInsight, Astigmatism market size is expected to grow at a moderate CAGR by 2032.
  • Leading Astigmatism companies working in the market are Novartis AG, SeaVision USA, Johnson & Johnson, Bausch & Lomb Incorporated, CooperVision, Orion Vision Group and many others
  • Key Astigmatism Therapies expected to launch in the market are Clariti 1day, Biotrue ONEday, Nano-Drops, And Many Others
  • According to an article published by OMICS International Journals titled “Astigmatism”, the prevalence of astigmatism in Israel, from data of medical examinations of an unselected population of 312,149 subjects ages 17 to 19 years, astigmatism in both eyes was found in 16.27% of the population. The prevalence of astigmatism was 1.69%. The various errors of astigmatism were more common among females.
  • According to secondary sources, Astigmatism could have a similar incidence/prevalence in females and males.


Astigmatism Overview

Astigmatism is a common and generally treatable imperfection in the curvature of the eye that causes blurred distance and near vision.

Astigmatism occurs when either the front surface of the eye (cornea) or the lens inside the eye has mismatched curves. Instead of having one curve like a round ball, the surface is egg-shaped. This causes blurred vision at all distances.

Astigmatism is often present at birth and may occur in combination with nearsightedness or farsightedness. Often it’s not pronounced enough to require corrective action. When it is, treatment options are corrective lenses or surgery.


Learn more about Astigmatism treatment algorithms in different geographies, and patient journeys. Contact to receive a sample @


Astigmatism Market

The Astigmatism market outlook of the report helps to build a detailed comprehension of the historical, current, and forecasted Astigmatism market trends by analyzing the impact of current Astigmatism therapies on the market and unmet needs, and drivers, barriers, and demand for better technology.

This segment gives a thorough detail of the Astigmatism market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Astigmatism market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Astigmatism market in 7MM is expected to witness a major change in the study period 2019-2032.


Astigmatism Epidemiology

The Astigmatism epidemiology section provides insights into the historical and current Astigmatism patient pool and forecasted trends for seven individual major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the Astigmatism market report also provides the diagnosed patient pool, trends, and assumptions. 


Explore more about Astigmatism Epidemiology @


Astigmatism Drugs Uptake

This section focuses on the uptake rate of the potential Astigmatism drugs recently launched in the Astigmatism market or expected to be launched in 2019-2032. The analysis covers the Astigmatism market uptake by drugs, patient uptake by therapies, and sales of each drug.

Astigmatism Drugs Uptake helps in understanding the drugs with the most rapid uptake and the reasons behind the maximal use of new drugs and allows the comparison of the drugs based on Astigmatism market share and size, which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.


Astigmatism Pipeline Development Activities

The Astigmatism report provides insights into different therapeutic candidates in Phase II, and Phase III stages. It also analyses Astigmatism key players involved in developing targeted therapeutics.


Request for a sample report to understand more about the Astigmatism pipeline development activities @


Astigmatism Therapeutics Assessment

Major key companies are working proactively in the Astigmatism Therapeutics market to develop novel therapies which will drive the Astigmatism treatment markets in the upcoming years are Novartis AG, SeaVision USA, Johnson & Johnson, Bausch & Lomb Incorporated, CooperVision, Orion Vision Group and many others.


Learn more about the emerging Astigmatism therapies & key companies @


Astigmatism Report Key Insights

1. Astigmatism Patient Population

2. Astigmatism Market Size and Trends

3. Key Cross Competition in the Astigmatism Market

4. Astigmatism Market Dynamics (Key Drivers and Barriers)

5. Astigmatism Market Opportunities

6. Astigmatism Therapeutic Approaches

7. Astigmatism Pipeline Analysis

8. Astigmatism Current Treatment Practices/Algorithm

9. Impact of Emerging Therapies on the Astigmatism Market


Table of Contents

1. Key Insights

2. Executive Summary

3. Astigmatism Competitive Intelligence Analysis

4. Astigmatism Market Overview at a Glance

5. Astigmatism Disease Background and Overview

6. Astigmatism Patient Journey

7. Astigmatism Epidemiology and Patient Population

8. Astigmatism Treatment Algorithm, Current Treatment, and Medical Practices

9. Astigmatism Unmet Needs

10. Key Endpoints of Astigmatism Treatment

11. Astigmatism Marketed Products

12. Astigmatism Emerging Therapies

13. Astigmatism Seven Major Market Analysis

14. Attribute Analysis

15. Astigmatism Market Outlook (7 major markets)

16. Astigmatism Access and Reimbursement Overview

17. KOL Views on the Astigmatism Market

18. Astigmatism Market Drivers

19. Astigmatism Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer


About DelveInsight

DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States